The Role of Artificial Intelligence in Integrated Marketing Communications: An Evaluation of Pharmaceutical Retail Firms in Nairobi County, Kenya
European Journal of Business and Strategic Management · 28.04.2026 · 11 (1) · 57-80
DOI: 10.47604/ejbsm.3729 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Business and Strategic Management, online erschienen am 28.04.2026. Verfasst von Winnie Njeru und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
This study examined the role of AI in enhancing IMC among pharmaceutical retail firms in Nairobi City County, Kenya. This is informed by how Artificial Intelligence (AI) is increasingly reshaping pharmaceutical marketing by enabling data driven decision making, personalization, and multichannel communication integration globally but empirical evidence on its role in Integrated Marketing Communication (IMC) within pharmaceutical retail contexts in Kenya remains limited. Methodology: A mixed-method design was adopted, combining survey data from 261 usable responses (89.7% response rate) drawn from 291 sampled pharmacies with systematic analysis of peer-reviewed literature, industry reports, and policy and regulatory frameworks. Descriptive, correlation, and regression analyses were used alongside thematic analysis of qualitative data.
Findings
Findings indicate moderate but growing AI adoption, with automation and mobile-based tools being the most widely implemented, while predictive analytics and personalization remain less developed. IMC practices were found to be mobile-driven but partially fragmented, with promotional integration lagging behind other dimensions. Correlation results show strong positive relationships between AI and IMC dimensions (r = 0.42–0.73), while regression analysis confirms that AI significantly predicts IMC performance (R² = 0.55–0.66). Qualitative findings further reveal that AI enhances communication efficiency and consistency but is constrained by system fragmentation, limited data maturity, and strict pharmaceutical regulatory frameworks. Overall AI is a critical enabler of IMC in pharmaceutical retail firms; however, its impact is moderated by organizational and regulatory constraints. Unique Contribution to Theory, Practice and Policy: The study contributes to theory by proposing a transitional AI–IMC maturity model, where AI is operational and fully strategic in driving integrated communication systems and by extending IMC, Technology Acceptance Model (TAM), and Customer Relationship Management (CRM) frameworks through the integration of AI as a structural enabler. Practically, it highlights the need for system integration, investment in data capabilities, and regulatory alignment. Policy implications emphasize balanced regulatory frameworks that support innovation while ensuring ethical pharmaceutical communication.
Zitieren
APA
Njeru, W., & Mukuria, J. (2026). The Role of Artificial Intelligence in Integrated Marketing Communications: An Evaluation of Pharmaceutical Retail Firms in Nairobi County, Kenya. European Journal of Business and Strategic Management, 11(1), 57-80. https://doi.org/10.47604/ejbsm.3729
Vancouver
Njeru W, Mukuria J. The Role of Artificial Intelligence in Integrated Marketing Communications: An Evaluation of Pharmaceutical Retail Firms in Nairobi County, Kenya. European Journal of Business and Strategic Management. 2026;11(1):57-80. doi:10.47604/ejbsm.3729
BibTeX
@article{Njeru2026,
author = {Njeru, Winnie and Mukuria, Jesse},
title = {The Role of Artificial Intelligence in Integrated Marketing Communications: An Evaluation of Pharmaceutical Retail Firms in Nairobi County, Kenya},
journal = {European Journal of Business and Strategic Management},
year = {2026},
volume = {11},
number = {1},
pages = {57--80},
doi = {10.47604/ejbsm.3729}
}
EUVIMED